Literature DB >> 22169395

Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.

Stéphanie Millecamps1, Philippe Corcia, Cécile Cazeneuve, Séverine Boillée, Danielle Seilhean, Véronique Danel-Brunaud, Nadia Vandenberghe, Pierre-François Pradat, Nadine Le Forestier, Lucette Lacomblez, Gaëlle Bruneteau, William Camu, Alexis Brice, Vincent Meininger, Eric LeGuern, François Salachas.   

Abstract

Mutations in UBQLN2 encoding ubiquilin-2 have recently been identified in families with dominant X-linked juvenile and adult-onset amyotrophic lateral sclerosis (ALS) and ALS/dementia. Ubiquilin-2 is a component of the ubiquitin inclusions detected in degenerating neurons in ALS patients. All the previously reported UBQLN2 mutations were localized in 1 of the 12 PXX domains of ubiquilin-2 protein. We sequenced UBQLN2 in 130 French patients with familial ALS (FALS) and absence of male-to-male transmission and the PXX domain in 240 more patients with sporadic ALS (SALS). We identified, at the heterozygote state, the c.1500_1508delCATAGGCCC, p.Gly502_Ile504del, in 1 affected woman. This deletion presumably leads to the in-frame deletion of 1 PXX repeat in the protein. This variant did not segregate with the disease in the corresponding family and was also detected in 1/380 control subject. Our results suggest that UBQLN2 gene mutations are rare in French ALS. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169395     DOI: 10.1016/j.neurobiolaging.2011.11.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  14 in total

1.  Molecular evaluation of human ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients.

Authors:  Isabel Hernández; Anna Espinosa; Luis Miguel Real; Jose Jorge Galán; Ana Mauleón; Maiteé Rosende Roca; Lluís Tárraga; Agustín Ruiz; Mercè Boada
Journal:  J Neurol       Date:  2012-06-24       Impact factor: 4.849

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 3.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

Review 4.  Misregulated RNA processing in amyotrophic lateral sclerosis.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; C Frank Bennett; Don W Cleveland; Gene W Yeo
Journal:  Brain Res       Date:  2012-03-03       Impact factor: 3.252

Review 5.  How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?

Authors:  Marka van Blitterswijk; Mariely DeJesus-Hernandez; Rosa Rademakers
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

Review 6.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

7.  The distinct genetic pattern of ALS in Turkey and novel mutations.

Authors:  Aslıhan Özoğuz; Özgün Uyan; Güneş Birdal; Ceren Iskender; Ece Kartal; Suna Lahut; Özgür Ömür; Zeynep Sena Agim; Aslı Gündoğdu Eken; Nesli Ece Sen; Pınar Kavak; Ceren Saygı; Peter C Sapp; Pamela Keagle; Yeşim Parman; Ersin Tan; Filiz Koç; Feza Deymeer; Piraye Oflazer; Haşmet Hanağası; Hakan Gürvit; Başar Bilgiç; Hacer Durmuş; Mustafa Ertaş; Dilcan Kotan; Mehmet Ali Akalın; Halil Güllüoğlu; Mehmet Zarifoğlu; Fikret Aysal; Nilgün Döşoğlu; Kaya Bilguvar; Murat Günel; Özlem Keskin; Tahsin Akgün; Hilmi Özçelik; John E Landers; Robert H Brown; A Nazlı Başak
Journal:  Neurobiol Aging       Date:  2015-01-10       Impact factor: 4.673

8.  Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS.

Authors:  Paloma González-Pérez; Yubing Lu; Ru-Ju Chian; Peter C Sapp; Rudolph E Tanzi; Lars Bertram; Diane McKenna-Yasek; Fen-Biao Gao; Robert H Brown
Journal:  Neurobiol Dis       Date:  2012-07-03       Impact factor: 5.996

9.  Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.

Authors:  Serena Lattante; Stéphanie Millecamps; Giovanni Stevanin; Sophie Rivaud-Péchoux; Carine Moigneu; Agnès Camuzat; Sandra Da Barroca; Emeline Mundwiller; Philippe Couarch; François Salachas; Didier Hannequin; Vincent Meininger; Florence Pasquier; Danielle Seilhean; Philippe Couratier; Véronique Danel-Brunaud; Anne-Marie Bonnet; Christine Tranchant; Eric LeGuern; Alexis Brice; Isabelle Le Ber; Edor Kabashi
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

Review 10.  Recent advances in the genetics of the ALS-FTLD complex.

Authors:  Huw R Morris; Adrian J Waite; Nigel M Williams; James W Neal; Derek J Blake
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.